A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

Clinical trial NCT04940390 · COMPLETED

Trial details

NCT number: NCT04940390
Sponsor: Satsuma Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Migraine With Aura Migraine Without Aura

Start date: 2021-06-30
Primary completion: 2022-10-13
Enrollment: 1591

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.